Intensified Downstream Processing for Biosimilars: Proof of Concept

On-Demand Webinar

Intensified Downstream Processing for Biosimilars: Proof of Concept

Effective manufacturing of biosimilars enhances patient access to affordable therapies. This webinar presents insights from two comparative studies focused on reducing the cost of goods (COGs) in biosimilar production through continuous processing and multi-column chromatography (MCC).

What You Will Learn:

Learn how to decrease COGs in biosimilar manufacturing
See how continuous processing can increase productivity within a chromatography step
Discover how membranes in MCC mode can remove downstream processing bottlenecks

Clear form data

Please Complete the Form

First Name *

Last Name *

E-Mail *

Phone Number *

Company *

Job Title *

Address *

Country *

Postal Code *

I would like to sign up for newsletters from Sartorius (Sartorius AG and its affiliated companies) based of my personal interests.
I can revoke my consent at any time with effect for the future by sending an e-mail to unsubscribe@sartorius.com or by clicking on the "unsubscribe" link in e-mails I have received.

* These fields are required Information on the use of your data can be found in our privacy policy

Complete Form to Register

Vincent Dechavanne

Senior Scientist II, DSP Process Development, Fresenius Kabi Biopharma, Switzerland 

Vincent holds a Master 2 of Science. He has over 28 years of experience in the field of downstream processing within several international biotech companies. He joined Fresenius Kabi SwissBiosim GmbH in December 2019 and is currently Senior Scientist II, DSP Process Development. He has a strong experience in research & development, manufacturing, MSAT, and tech transfer.